Ignite Creation Date:
2025-12-24 @ 1:29 PM
Ignite Modification Date:
2025-12-26 @ 9:42 PM
Study NCT ID:
NCT01710995
Status:
COMPLETED
Last Update Posted:
2012-10-19
First Post:
2012-08-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Three-Period Study to Investigate the Relative Bioavailability and Pharmacodynamic Profiles of a Zegerid 20mg Capsule, Zegerid 20mg Powder for Oral Suspension and Losec 20mg Capsule in Healthy Adult Volunteers Under Fasting Conditions
Sponsor:
Norgine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-10
Start Date Type:
None
Primary Completion Date:
2010-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-02
Completion Date Type:
ACTUAL
First Submit Date:
2012-08-03
First Submit QC Date:
None
Study First Post Date:
2012-10-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-10-17
Last Update Post Date:
2012-10-19
Last Update Post Date Type:
ESTIMATED